Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (188)	11/10/2000 10:18:12 AM
From: scaram(o)uche	Respond to of 724

It's so frustrating to be an investor in a company with incompetent management, when the guys in control believe that they're good. An undervalued jewel, IMO. If Eichenbaum would just resign. Sigh.

To: scaram(o)uche who wrote (188)	11/10/2000 10:26:25 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 724

Order levels are also solid as evidenced by the more than 48 percent increase in consolidated backlog since the beginning of the year. Approximately flat with the level at the end of the second quarter, the backlog now stands at $12.7 million, versus $8.6 million at December 31, 1999. Of course, everyone understands that there is turnover is back orders. Old ones are canceled, and.... given Freedman's capacities, some new ones will be as well. That's life, and it's the reason why this bargain is handed to us (my opinion only, and it's a very frustrated opinion.... please get your own!). We believe DGI needs to become financially self-sufficient in the near term. We are continuing actively to explore means to accomplish this." Notice the passive stance in the first sentence, and the active stance in the second. Incredible clowns. Clowns of a magnitude that hasn't been observed in biotech since...... shudder..... Galton.